| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
As the leading cause of preventable disease and death in the United States, tobacco use can contribute to the development of cardiovascular disease, cancer, and respiratory illness. Tobacco use disorder is recognized as a medical condition by the American Psychiatric Association, and testing is a powerful tool that helps physicians identify and treat this condition. Mayo Clinic Laboratories offers a suite of testing options to quantify and monitor nicotine use.
Nicotine test menu
We offer serum testing to quantify nicotine and its primary metabolite, cotinine, as well as urine testing to quantify nicotine, cotinine, nornicotine (another metabolite), and anabasine (an alkaloid found in tobacco plants but not in nicotine replacement therapies).
Tobacco users engaged in programs to abstain from tobacco require support in the form of counseling, pharmacotherapy, and continuous encouragement. Quantification while patients are using tobacco helps tailor nicotine replacement doses early in cessation treatment. Random nicotine testing can also monitor patient compliance. If the results of testing indicate the patient is actively using a tobacco product during therapy, additional counseling or intervention may be appropriate.
In addition, nicotine testing can be used to confirm nicotine-use cessation before anesthesia and as part of initial insurance policy assessments.
Key testing
Highlights
Tobacco use is the leading cause of preventable death in the United States. In this test-specific episode of the "Answers From the Lab" podcast, Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients in smoking cessation programs and other settings.
Our comprehensive addiction medicine profile can help identify polysubstance use disorder as well as assess and manage patients at risk for substance use disorder.
Key testing
Highlights
Tobacco use is the leading cause of preventable death in the United States. In this test-specific episode of the "Answers From the Lab" podcast, Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients in smoking cessation programs and other settings.